ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : TARGETING
Clear All
Filter by Field of Research
Haematology (8)
Medical and Health Sciences (8)
Biochemistry And Cell Biology Not Elsewhere Classified (4)
Genetic Development (Incl. Sex Determination) (4)
Developmental Genetics (incl. Sex Determination) (3)
Oncology And Carcinogenesis (3)
Protein Targeting And Signal Transduction (3)
Surgery (3)
Cardiology (incl. Cardiovascular Diseases) (2)
Food properties (incl. characteristics and health benefits) (2)
Medical biochemistry - carbohydrates (2)
Medical infection agents (incl. prions) (2)
Neurogenetics (2)
Nutrigenomics and personalised nutrition (2)
Oncology and Carcinogenesis (2)
Biotechnology Not Elsewhere Classified (1)
Cell Development (Incl. Cell Division And Apoptosis) (1)
Cell Metabolism (1)
Cellular Interactions (Incl. Adhesion, Matrix, Cell Wall) (1)
Clinical Pharmacology and Therapeutics (1)
Clinical microbiology (1)
Diagnostic radiography (1)
Endocrinology (1)
Gene and Molecular Therapy (1)
Genetic Immunology (1)
Genetics (1)
Haematological Tumours (1)
Humoural immunology and immunochemistry (1)
Infectious Diseases (1)
Medical Bacteriology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (94)
Filter by Status
Closed (94)
Filter by Scheme
NHMRC Project Grants (94)
Filter by Country
Australia (1)
Filter by Australian State/Territory
SA (1)
  • Researchers (0)
  • Funded Activities (94)
  • Organisations (30)
  • Funded Activity

    Analysis Of Mice Lacking LH-2 Gene

    Funder
    National Health and Medical Research Council
    Funding Amount
    $146,609.00
    More information
    Funded Activity

    Unique Mechanisms Of Plasma Membrane Protein Sorting In Endothelial Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $159,140.00
    More information
    Funded Activity

    Molecular Biological Studies Of Insulin-stimulated Gluc Ose Transport

    Funder
    National Health and Medical Research Council
    Funding Amount
    $265,915.00
    More information
    Funded Activity

    Assessing The Role Of The Myelin Oligodendrocyte Glycop Rotein In An MS-like Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $184,086.00
    More information
    Funded Activity

    IMMUNOTARGETED NANOPARTICLES TO IMPROVE TUMOUR DELIVERY OF CHEMOSENSITISING CYTOTOXIC DRUGS AND B-RADIATION

    Funder
    National Health and Medical Research Council
    Funding Amount
    $548,985.00
    Summary
    This project aims to develop nano-bullets for advanced cancer therapy and nano-probes for the early assessment of cancer treatment responses, improved patient outcomes and reducing drug development time. Specially engineered, antibody-coated nanoparticles are targeted to dead cancer cells, present in untreated cancer but increased after therapy, for (1) tumour site specific delivery of increased drug or radiation dose than currently achieved and (2) monitoring the tumour response to therapy.
    More information
    Funded Activity

    A Transgenic Analysis Of The Basis For Growth Signalling By The Growth Hormone Receptor

    Funder
    National Health and Medical Research Council
    Funding Amount
    $209,455.00
    More information
    Funded Activity

    Invivo And Invetro Studies Of Thrombomodulin Modular Re Gulation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $349,338.00
    More information
    Funded Activity

    NUCLEAR AND TRANSGOLGI TARGETING AND MEMBRANE INDUCTION BY DENGUE NS5 RNA-DEPENDENT RNA POLYMERASE INTERDOMAIN REGION

    Funder
    National Health and Medical Research Council
    Funding Amount
    $450,750.00
    Summary
    Dengue virus is the causative agent of a mosquito-borne disease, Dengue fever, relevant to northern Queensland, where antibodies from a previous infection can complex with virus of a different serotype in a subsequent infection, and cause a severe, potentially fatal form of the disease (Dengue haemorrhagic fever-Dengue shock syndrome). The present proposal seeks to further understanding of the role of the dengue RNA-dependent RNA polymerase NS5, which is essential for viral RNA replication, with .... Dengue virus is the causative agent of a mosquito-borne disease, Dengue fever, relevant to northern Queensland, where antibodies from a previous infection can complex with virus of a different serotype in a subsequent infection, and cause a severe, potentially fatal form of the disease (Dengue haemorrhagic fever-Dengue shock syndrome). The present proposal seeks to further understanding of the role of the dengue RNA-dependent RNA polymerase NS5, which is essential for viral RNA replication, within the viral infectious cycle. We intend to examine the subcellular targeting properties of a short central region (the interdomain) of NS5, which appears to play multiple roles in targeting to both the perinuclear Golgi-membranes and to the nucleus, as well as in inducing intracellular membranes derived from the Golgi which are the site of viral replication. We will determine how NS5 localisation-membrane induction may differ in insect and primate cells, and attempt to isolate binding partners of NS5 from the nucleus and Golgi compartment of insect and primate cells using various different approaches. Our studies should assist in understanding NS5's critical role in the Dengue infectious cycle, and contribute towards devising new anti-viral strategies such as vaccination and-or therapies targeted at the NS5 interdomain.
    Read more Read less
    More information
    Funded Activity

    Making Mice Lacking Brain Cells Co-ordinating Locomotio N

    Funder
    National Health and Medical Research Council
    Funding Amount
    $109,666.00
    More information
    Funded Activity

    Mouse Model For Ataxia-telangiectasia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $55,586.00
    More information

    Showing 1-10 of 94 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback